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Mode of Proximal tubule Damage: 
Differential cause for the release  
of tFF3?
Zinah Zwaini1,2† , Dalia Alammari1† , Simon Byrne1 and Cordula Stover1*
1 Department of Infection, Immunity and Inflammation, College of Medicine, Biological Sciences and Psychology, University of 
Leicester, Leicester, UK, 2 Kufa College of Medicine, Najaf, Iraq
Proximal tubular epithelial cells are particularly sensitive to damage. In search of a bio-
marker, this study evaluated the potential of different cell activation models (hypoxia/
replenishment and protein overload) to lead to a release of trefoil factor 3 (TFF3). 
Surprisingly, we found disparity in the ability of the different stimuli to enhance the 
intracellular abundance of TFF3 and its release: while conditions of nutrient starvation 
and damage associated with replenishment lead to intracellular abundance of TFF3 in 
the absence of TFF3 release, stimulation with an excess amount of albumin did not 
yield accumulation of TFF3. By contrast, incubation of cells with a purified λ light chain 
preparation from a patient with multiple myeloma provoked the presence of TFF3 in the 
cell supernatant. We, therefore, propose that elevations of TFF3 in renal disease might 
be more revelatory for the cause of restitution than previously thought.
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iNtrODUctiON
Trefoil factor 3 (TFF3) has a role in restitution (cell migration to heal superficial lesions) and regen-
eration (differentiation and proliferation as repair) of epithelia. Contrasting with genes that encode 
other members of the TFF peptide family, TFF3 mRNA is expressed in the cortex of the kidney (1). 
TFF3 peptide was readily detectable in urine from patients with nephrolithiasis compared to normal 
urine (1). Elevated levels were also found in urine from patients with incident chronic kidney disease 
as part of a nested study with a median follow up time of nearly 9 years (2) as well as in serum of 
patients with chronic kidney disease stages 1–5 (3). Possible triggers for the release of TFF3 may 
include damage or inflammation (2).
We have developed in vitro models that target cells of the proximal tubular epithelial cell line 
HK-2 in different ways: a phase of hypoxia/nutrient starvation (HNS) and subsequent replenishment 
with medium models the injury observed in ischemia reperfusion; stimulation of HK-2 cells with 
immunoglobulin light chains (LCs) or albumin devoid of fatty acids models effects of monoclonal 
gammopathy and elevated protein, respectively.
The aim of this study was to compare and contrast TFF3 release in response to these experimental 
conditions.
MAteriALs AND MetHODs
For the HNS–replenishment (HNSR) model, phenolphthalein containing growth medium 
[DMEM:F-12 (Thermo Fisher Scientific Ltd.) with l-glutamine (200  mM), 10% (v/v) fetal calf 
serum (FCS), 200 μg/ml recombinant human epidermal growth factor (Sigma-Aldrich Company 
FiGUre 1 | Densitometric analysis of proteome array reactivities for tFF3 (A) and characteristic markers of hypoxia (FABP1, veGF) and inflammation 
(cXcL16) (B) using cell lysates from HK-2 cells exposed to hypoxia/nutrient starvation (HNs) and replenishment (HNsr) for 24 and 48 h. Densities 
obtained are shown in (c). These were normalized to a reference (pos) and the background was subtracted. Data are presented as mean ± SD and were compared 
using Student’s multiple t-test. p < 0.05 was considered statistically significant. GraphPad Prism 6.07 was used for statistical analysis (GraphPad Software, La Jolla, 
CA, USA). HIF-1α abundance is increased at the early replenishment time point when normalized to a housekeeping protein β-actin and compared to the normoxic 
control (D). Normalized abundance of TFF3 (7 kDa) in cell lysates from HK-2 cells exposed to hypoxia/nutrient starvation (HNS) and replenishment for 24 and 48 h 
(e). NDL, normalized density to loading control (Western blot).
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Ltd., Dorset, UK), penicillin (100  IU/ml), and streptomycin 
(100 μg/ml)] was replaced with serum-free glucose-free Locke’s 
buffer (154 mM NaCl, 5.6 mM KCl, 2.3 mM CaCl2, 1 mM MgCl2, 
3.6  mM NaHCO3, and 5  mM HEPES, pH 7.2) and proximal 
tubular epithelial cells of normal human kidney (HK-2) (ATCC 
CRL-2190) were exposed to a customized gas mixture (0.5% O2, 
5% CO2, 94.5%N2; BOC Ltd., Guildford, UK) in a custom-made 
chamber (S. Byrne and University of Leicester workshop). After 
6 h at 37°C, the cells were replenished with growth medium and 
returned to 5% CO2 for 24 and 48 h (37°C), respectively.
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FiGUre 2 | the human kidney biomarker array (r&D systems) was used to analyze tFF3 abundance in lysates from cells exposed to 
immunoglobulin λ light chain (Lc) and fatty acid free human serum albumin (FAF-HsA) for 72 h in comparison with control cells (A). Densities were 
normalized to a reference (pos), background subtracted and are expressed as ±SD. (B) Abundance of TFF3 (in relation to β-actin) in cell lysates from HK-2 cells 
exposed 5 mg/ml immunoglobulin λ light chain (LC) or fatty acid-free human serum albumin (FAF-HSA) for 72 h (Western blot). (c) ELISA of TFF3 in the 
supernatants of HK-2 stimulated with 5 mg/ml LC and FAF-HSA. Untreated cells were used as control. Two independent experiments for the distinct stimulations  
for 24 and 72 h are shown.
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For the protein stimulation model, HK-2 cells were grown 
in phenolphthalein containing DMEM:F-12 supplemented 
with l-glutamine, 15 mM HEPES, 10% (v/v) FCS, recombinant 
human epidermal growth factor (200 μg/ml), insulin/transfer-
rin/sodium selenite (ITS), triiodothyronine (4  pg/ml), and 
hydrocortisone (100 μg/ml). The cells were sub-cultured in six-
well plates for 24 h. Then, medium was changed to serum-free 
medium with 5 mg/ml human serum albumin essentially free of 
fatty acids (FAF-HSA) (Sigma) diluted in endotoxin-free water 
or λ LCs purified by chromatography from the urine of a patient 
with multiple myeloma. The efficiency of endotoxin removal 
from the preparation by High-Capacity Endotoxin Removal 
Spin Column (Thermo Fisher Scientific) was confirmed by 
chromogenic Limulus amebocyte lysate assay kit (Pierce). Cells 
were stimulated for 24 and 72  h. A tubulotoxic effect of fatty 
acid carrying albumin has previously been shown in vitro at 24 h 
of stimulation using primary human proximal tubular cells (4). 
Newman et al. used human serum albumin 95% pure and free 
of fatty acid for their stimulation experiments in concentrations 
from 0.05 to 5 mg/ml to cover the range of the normal and the 
pathological condition in kidneys (5). Five grams per liter were 
the concentration of λ LC recorded for the multiple myeloma 
patient’s 24-h urine.
Protein lysates (200 μg) were prepared from both experiments 
and analyzed by R&D Systems Proteome Profiler™ Human 
Kidney Biomarker Array Kit. Image J 1.49 software was used to 
quantify intensities on developed X-ray film. For Western blot-
ting, rabbit anti HIF-1α (1:500, Biorbyt) and mouse anti β-actin 
(clone AC-74, 1:5000, Sigma) were used as primary antibodies. 
HRP-conjugated swine anti-rabbit immunoglobulins (1:3000, 
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DAKO) and goat anti-mouse immunoglobulins (1:2000, DAKO) 
were used for detection with ECL reagents (Pierce). TFF3 anti-
body was purchased from Biorbyt Ltd. (Cambridge, UK) and 
used at 1:500 with DAKOmate Envision detection kit (1:40). V.5 
Image Lab software (BioRad) was used to quantify reactivities on 
developed X-ray films. TFF3 was measured by R&D Systems™ 
Quantikine® ELISA human TFF3 immunoassay (Minneapolis, 
MN, USA), and levels were calculated using a linear standard 
curve. Undiluted supernatants were used.
resULts AND DiscUssiON
Nutrient starvation and hypoxia were sufficient triggers for 
increased TFF3 abundance in lysates from HK-2 cells, and this 
was maintained during the replenishment phase at 24 and 48 h 
(Figures 1A,C). In this acute phase (24 h), effectors of hypoxia-
induction (VEGF, FABP1, CXCL16) were greatly increased 
compared to control cells (Figures 1B,C). HIF-1α was elevated 
at this time point (Figure 1D). Transcription of VEGF, HIF-1, 
and TFF3 mRNA is induced by hypoxia in vitro (6, 7), CXCL6 
gene promoter has a hypoxia-sensitive response element (8), 
and FABP has been described as a marker of hypoxic renal cell 
damage (9, 10). CXCL16 and VEGF remained elevated compared 
to the control at 48-h medium replenishment. A commercial 
ELISA did not detect TFF3 in the cell supernatant, therefore, 
TFF3 was deemed to be below the detection limit of 39 pg/ml. 
This contrasts with the abundance of TFF3 found in HK-2 cell 
lysates: Western blot analysis of cell lysates confirmed the pres-
ence of TFF3 in lysates (Figure 1E), implying the detection of an 
intracellular form of TFF3 (11). While it is known that TFF3 is 
regulated by HIF-1α (12), it is not known how hypoxic damage 
or the temporary withdrawal of insulin (13) might alter secretion 
of TFF3.
By contrast, when analyzing in parallel HK-2 cells exposed 
to pathological concentrations of endotoxin free protein (immu-
noglobulin λ LC or human serum albumin, devoid of bound 
fatty acids), VEGF, FABP1, and CXCL16 were not increased 
at the 72  h time point of this in  vitro model compared to the 
unstimulated control cells (data not shown). TFF3 abundance, 
however, was markedly elevated in those lysates obtained from 
cells exposed to the λ LC preparation, but not in lysates from 
HK-2 cells exposed to the same concentration of albumin 
(Figure 2A). Western blot analysis of cell lysates validated this 
observation: λ LC-stimulated cells showed markedly elevated 
TFF3 abundance, contrasting with untreated and human serum 
albumin-stimulated cells (Figure  2B). A commercial ELISA 
quantified TFF3 in supernatants of another identical experi-
ment: nanogram amounts of the peptide were detectable from 
λ LC-stimulated HK-2 cells, whereas albumin-stimulated HK-2 
cells were negative (Figure 2C).
We conclude that immunoglobulin LCs initiate more restitu-
tion in proximal tubular epithelial cells in vitro than albumin. 
Contrary to benign monoclonal gammopathy, which is not 
necessarily kidney damaging, monoclonal gammopathy of 
renal significance is not subclinical, and requires aggressive 
treatment (14). Amino acid changes in LC sequences may 
confer considerable toxicity to proximal tubular epithelial cells 
(15). In these cases, longitudinal measurements of TFF3 could 
be warranted.
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